We’ve spent the past year developing Molecule, a software protocol that will provide a new distributed ownership structure for drug development. It will unite researchers, biotechs, investors and patients in public marketplaces that democratize research capital allocation and create novel collaboration and data sharing incentives. Our ultimate goal is to…